ArticleNature reviews. Cardiology2013
Cost-effectiveness of heart failure therapies.
Article in Nature reviews. Cardiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Cost-Effectiveness of Therapies for Heart Failure in Brazil: A Systematic Review.Arquivos brasileiros de cardiologia · 2026Pooled it
- Cost-Utility of Venoarterial Extracorporeal Membrane Oxygenation in Refractory Cardiogenic Shock: A Brazilian Perspective Study.Arquivos brasileiros de cardiologia · 2024Pooled it
- Optimal effectiveness of heart failure management - an umbrella review of meta-analyses examining the effectiveness of interventions to reduce (re)hospitalizations in heart failure.Heart failure reviews · 2022Pooled it
- The impact of adherence on costs and effectiveness of telemedical patient management in heart failure: a systematic review.Applied clinical informatics · 2014Pooled it
- Conduction System Pacing vs Biventricular Pacing in Chronic Heart Failure: Protocol for the Economic Analysis of the PhysioSync-HF Trial.Arquivos brasileiros de cardiologia · 2025Trial
- Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate.Clinical research in cardiology : official journal of the German Cardiac Society · 2019Trial
- Pulmonary artery pressure-guided heart failure management: US cost-effectiveness analyses using the results of the CHAMPION clinical trial.European journal of heart failure · 2017Trial
- EcoRxAgent: an AI agent for generating economically substitutable prescriptions.NPJ digital medicine · 2026Article
- Integrating Findings Into Practice: Assessing External Validity of Congestive Heart Failure Trials.Cardiology research · 2026Article
- Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCEPharmacoEconomics - open · 2024Review
- Application of recommended therapies among patients with heart failure during the Syrian conflict: reality and barriers.ESC heart failure · 2022Article
- Cost-of-disease of Heart Failure in Turkey: A Delphi Panel-based Analysis of Direct and Indirect Costs.Balkan medical journal · 2022Article
- The Peripheral Circulating Exosomal microRNAs Related to Central Inflammation in Chronic Heart Failure.Journal of cardiovascular translational research · 2022Article
- Cost effectiveness analyses of pharmacological treatments in heart failure.Frontiers in pharmacology · 2022Review
- Determination and stability of N-terminal pro-brain natriuretic peptide in saliva samples for monitoring heart failure.Scientific reports · 2021Article
- The Role of Prevention in Reducing the Economic Impact of ME/CFS in Europe: A Report from the Socioeconomics Working Group of the European Network on ME/CFS (EUROMENE).Medicina (Kaunas, Lithuania) · 2021Article
- Cardiac contractility modulation for the treatment of heart failure with reduced ejection fraction.Heart failure reviews · 2021Review
- Evaluation of the prescribing practice of guideline-directed medical therapy among ambulatory chronic heart failure patients.BMC cardiovascular disorders · 2021Observational
- Cardiac Contractility Monitoring: an Important Therapy in the Treatment of Advanced Heart Failure.Current cardiology reports · 2020Review
- Enhancing all-in-one bioreactors by combining interstitial perfusion, electrical stimulation, on-line monitoring and testing within a single chamber for cardiac constructs.Scientific reports · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Management of HF involves accurate diagnosis and implementation of evidence-based treatment strategies. Costs related to the care of patients with HF have increased substantially over the past 2 decades, partly owing to new medications and diagnostic tests, increased rates of hospitalization, implantation of costly novel devices and, as the disease progresses, consideration for heart transplantation, mechanical circulatory support, and end-of-life care. Not surprisingly, HF places a huge burden on health-care systems, and widespread implementation of all potentially beneficial therapies for HF could prove unrealistic for many, if not all, nations. Cost-effectiveness analyses can help to quantify the relationship between clinical outcomes and the economic implications of available therapies. This Review is a critical overview of cost-effectiveness studies on key areas of HF management, involving pharmacological and nonpharmacological clinical therapies, including device-based and surgical therapeutic strategies.
Indexed as
Identifiers
23609174What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.